Skip to main content

Animations

MJFF Publications

8881 - 8890 of 9033 Results
Title
Year
  • Year
  • 2025
  • 2024
  • 2024
  • 2025
  • 2021
  • 2021
  • 2019
  • 2022
  • 2019
  • 2019
  • Summary Details
    OPEN
    Title: Passive Monitoring of Parkinson Tremor in Daily Life: A Prototypical Network Approach
    Journal Name: Sensors
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/s25020366
    Citation Count: 6
  • Summary Details
    OPEN
    Title: Cohort-specific boolean models highlight different regulatory modules during Parkinson’s disease progression
    Journal Name: iScience
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.isci.2024.110956
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Gut Microbial Metabolites and Future Risk of Parkinson's Disease: A Metabolome‐Wide Association Study
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mds.30054
    Citation Count: 11
  • Summary Details
    OPEN
    Title: Local Regulation of Striatal Dopamine Release Shifts from Predominantly Cholinergic in Mice to GABAergic in Macaques
    Journal Name: The Journal of Neuroscience
    Publisher: Society for Neuroscience
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1523/jneurosci.1692-24.2025
    Citation Count: 5
  • Summary Details
    OPEN
    Title: BDNF rs6265 Genotype Influences Outcomes of Pharmacotherapy and Subthalamic Nucleus Deep Brain Stimulation in Early-Stage Parkinson's Disease
    Journal Name: Neuromodulation: Technology at the Neural Interface
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1111/ner.13504
    Citation Count: 10
  • Summary Details
    OPEN
    Title: Age-associated insolubility of parkin in human midbrain is linked to redox balance and sequestration of reactive dopamine metabolites
    Journal Name: Acta Neuropathologica
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s00401-021-02285-4
    Citation Count: 60
  • Summary Details
    OPEN
    Title: Differences in topological progression profile among neurodegenerative diseases from imaging data
    Journal Name: eLife
    Publisher: eLife Sciences Publications, Ltd
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.7554/elife.49298
    Citation Count: 14
  • Summary Details
    OPEN
    Title: Small molecule C381 targets the lysosome to reduce inflammation and ameliorate disease in models of neurodegeneration
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: Proceedings of the National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1073/pnas.2121609119
    Citation Count: 49
  • Summary Details
    OPEN
    Title: Predicting severity and prognosis in Parkinson's disease from brain microstructure and connectivity
    Journal Name: NeuroImage: Clinical
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.nicl.2019.102111
    Citation Count: 42
  • Summary Details
    OPEN
    Title: Hsp110 mitigates α-synuclein pathology in vivo
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: Proceedings of the National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1073/pnas.1903268116
    Citation Count: 58
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.